Roy Sabo
Affiliations: | Biostatistics | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Biostatistics BiologyGoogle:
"Roy Sabo"Children
Sign in to add traineeHanan Hammouri | grad student | 2013 | VCU |
Shuxian Z. Sinks | grad student | 2013 | VCU |
Mary E. Haynes | grad student | 2014 | VCU |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Simmons GL, Sabo R, Martin E, et al. (2020) Parenteral Ascorbic Acid in Allogeneic HCT Recipients Is Safe and Ameliorates the Cytokine Milieu and Endothelial Injury Following Myeloablative Conditioning Biology of Blood and Marrow Transplantation. 26: S139-S140 |
Fegley AK, Sabo R, Roberts CH, et al. (2020) Favorable Clinical Outcomes with Valacyclovir for Cytomegalovirus Prophylaxis Following Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 26: S389 |
Krieger E, Sabo R, Moezzi S, et al. (2019) Killer Immunoglobulin-like Receptor-Ligand Interactions Predict Clinical Outcomes Following Unrelated Donor Transplants. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation |
McKay J, Al-Juhaishi T, Guanhua L, et al. (2019) Rive-CLL: Phase 1 Trial of Rituximab, Idelalisib, and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia Blood. 134: 5482-5482 |
Al-Juhaishi T, Sabo R, Roberts CH, et al. (2019) Short Course Mycophenolate Mofetil Yields Adequate Immune Reconstitution and Equivalent Alloreactivity Following Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 25: S332 |
Krieger E, Okhomina V, Sabo R, et al. (2019) 56+ Cell Reconstitution Kinetics in HLA Matched Unrelated Donor Allografts: What Doesn't Kill You Makes You Stronger Biology of Blood and Marrow Transplantation. 25: S324 |
Kobulnicky DJ, Sabo RT, Sharma S, et al. (2018) The influence of lymphoid reconstitution kinetics on clinical outcomes in allogeneic stem cell transplantation. Leukemia & Lymphoma. 1-9 |
Maples KT, Sabo RT, McCarty JM, et al. (2018) Maintenance azacitidine after myeloablative allogeneic hematopoietic cell transplantation for myeloid malignancies. Leukemia & Lymphoma. 1-6 |
Simmons GL, Ribeiro A, Sabo R, et al. (2018) Optimization of Anti-Thymocyte Globulin Administration Schedule in Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 24: S333-S334 |
Koparde V, Abdul Razzaq B, Suntum T, et al. (2017) Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation. Plos One. 12: e0187771 |